APRE - Aprea Therapeutics Inc
IEX Last Trade
3.38
0.051 1.521%
Share volume: 1,620
Last Updated: Fri 30 Aug 2024 09:19:29 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$3.33
0.05
1.54%
Summary score
23%
Profitability
25%
Dept financing
3%
Liquidity
50%
Performance
20%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-12.09%
Return on assets
-10.91%
Return on sales
0%
Return on invested capital
120.68%
Total debt ratio
11.64%
Debt ratio change over timeo
-0.91%
Current Ratio
9.71%
Quick Ratio
0%
Cash Position Ratio
9.55%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-12.09%
Return on assets
-10.91%
Return on sales
0%
Return on invested capital
120.68%
Total debt ratio
11.64%
Debt ratio change over timeo
-0.91%
Current Ratio
9.71%
Quick Ratio
0%
Cash Position Ratio
9.55%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-16.35%
Return on assets
-12.61%
Return on sales
0%
Return on invested capital
116.66%
Total debt ratio
12.8%
Debt ratio change over time
-0.85%
Current Ratio
7.88%
Quick Ratio
0%
Cash Position Ratio
7.78%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-110.95%
Return on assets
-109.34%
Return on sales
0%
Return on invested capital
4.47%
Total debt ratio
-91.12%
Debt ratio change over time
-0.91%
Current Ratio
8.27%
Quick Ratio
0%
Cash Position Ratio
8.11%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | APRE | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -12.09% | -3.05% | 11.55% | 6.27% |
| Return on assets | -10.91% | 3.6% | 3.57% | 5.27% |
| Return on sales | 0% | 32.14% | 42.16% | 33.08% |
| Return on invested capital | 120.68% | 5.09% | 7.99% | 13.19% |
| Profitability | 25% | 37% | 69% | 61% |
| Total debt ratio | 11.64% | 101.18% | 74.11% | 29.58% |
| Debt ratio change over time | -0.91% | 6.09% | 6.03% | 1.53% |
| Dept financing | 3% | 50% | 43% | 14% |
| Current Ratio | 9.71% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 9.55% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 16% | 36% | 36% |
| Short-term ratios | APRE | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -12.09% | -25.62% | 17.94% | 7.14% |
| Return on assets | -10.91% | 3.26% | 3.67% | 4.71% |
| Return on sales | 0% | 31.22% | 37.5% | 33.58% |
| Return on invested capital | 120.68% | 8.14% | 7.17% | 18.16% |
| Profitability | 25% | 40% | 71% | 61% |
| Total debt ratio | 11.64% | 105.33% | 83.42% | 27.49% |
| Debt ratio change over time | -0.91% | -23.44% | 9.66% | 0.6% |
| Dept financing | 3% | 25% | 45% | 8% |
| Current Ratio | 9.71% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 9.55% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 26% | 22% | 38% |